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Selenocysteine (Sec) tRNA (tRNA[Ser]Sec) serves as both the site of Sec biosynthesis and the adapter
molecule for donation of this amino acid to protein. The consequences on selenoprotein biosynthesis of
overexpressing either the wild type or a mutant tRNA[Ser]Sec lacking the modified base, isopentenyladenosine,
in its anticodon loop were examined by introducing multiple copies of the corresponding tRNA[Ser]Sec genes
into the mouse genome. Overexpression of wild-type tRNA[Ser]Sec did not affect selenoprotein synthesis. In
contrast, the levels of numerous selenoproteins decreased in mice expressing isopentenyladenosine-deficient
(i6A2) tRNA[Ser]Sec in a protein- and tissue-specific manner. Cytosolic glutathione peroxidase and mitochon-
drial thioredoxin reductase 3 were the most and least affected selenoproteins, while selenoprotein expression
was most and least affected in the liver and testes, respectively. The defect in selenoprotein expression occurred
at translation, since selenoprotein mRNA levels were largely unaffected. Analysis of the tRNA[Ser]Sec popula-
tion showed that expression of i6A2 tRNA[Ser]Sec altered the distribution of the two major isoforms, whereby
the maturation of tRNA[Ser]Sec by methylation of the nucleoside in the wobble position was repressed. The data
suggest that the levels of i6A2 tRNA[Ser]Sec and wild-type tRNA[Ser]Sec are regulated independently and that the
amount of wild-type tRNA[Ser]Sec is determined, at least in part, by a feedback mechanism governed by the level
of the tRNA[Ser]Sec population. This study marks the first example of transgenic mice engineered to contain
functional tRNA transgenes and suggests that i6A2 tRNA[Ser]Sec transgenic mice will be useful in assessing the
biological roles of selenoproteins.
Selenocysteine (Sec) is encoded by UGA in selenoprotein
mRNAs, making Sec the 21st naturally occurring amino acid in
protein (reviewed in references 6, 19, and 35). The usage of
UGA as a Sec codon represents the only addition to the ge-
netic code since the code was deciphered in the mid-1960s.
Decoding of UGA as Sec, rather than termination, requires
specific secondary structures in selenoprotein mRNAs, termed
Sec insertion sequences or SECIS elements, several trans-act-
ing factors, and a unique tRNA with an anticodon complemen-
tary to UGA. The tRNA is first aminoacylated with serine,
which serves as the backbone for the biosynthesis of Sec. Sec
tRNA is therefore designated tRNA[Ser]Sec. It is not recog-
nized by the standard elongation factor, eEFIA, but by a spe-
cialized factor, designated eEFsec, which exhibits specificity
for both the unique tRNA structure and the amino acid (16,
46). Recruitment of the Sec-tRNA-EFsec complex to the ri-
bosome occurs via its interaction with the SECIS binding pro-
tein 2, a protein exhibiting specificity for the SECIS elements
in selenoprotein mRNAs (12).
Selenoproteins typically contain only one Sec residue per
polypeptide and are expressed at relatively low levels com-
pared to most other cellular proteins. There are fewer than 10
known prokaryotic and 20 known eukaryotic selenoproteins,
but they provide a selective advantage to some organisms and
are essential to others (reviewed in reference 23). The central
component for the synthesis of the entire class of selenopro-
teins is tRNA[Ser]Sec. Thus, manipulation of the gene for this
tRNA provides a potential target for better understanding the
biological roles of this class of proteins. tRNA[Ser]Sec gene
knockout mice, however, are embryonic lethal (7). Although
this observation demonstrates an essentiality of selenoprotein
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expression in mammals, this lethality also precludes utilization
of these mice as a tool for studying selenoproteins. The ex-
pression of genetically altered tRNA[Ser]Sec genes in transgenic
mice offers an alternative approach to specifically perturb sel-
enoprotein biosynthesis and study the biological roles of sel-
enoproteins.
In higher vertebrates, selenoprotein expression is dictated by
two major isoacceptors that differ from each other by a single
29-O-methyl group on the ribosyl moiety of the modified resi-
due, methylcarboxymethyl-59-uridine (mcm5U), at position 34
(reviewed in references 19 and 23). Transfer RNA[Ser]Sec
methylation at position 34 results in the formation of methyl-
carboxymethyl-59-uridine-29-O-methylribose (mcm5Um). The
methylation step is responsive to selenium availability (9, 15,
22) and results in a conformational change in tRNA[Ser]Sec
(15). The unmethylated form, mcm5U, is therefore the precur-
sor of the methylated form, mcm5Um (10, 30). In mammalian
cells and tissues, selenium deficiency is associated with a shift
in the distribution of the two isoacceptors towards the mcm5U
isoform, while selenium supplementation typically results in a
shift towards the mcm5Um isoform (9, 15, 22). tRNA[Ser]Sec
also contains additional modified residues, including isopente-
nyladenosine (i6A) at position 37, pseudouridine (c) at posi-
tion 55, and 1-methyladenosine at position 58 (14). The meth-
ylation of mcm5U to form mcm5Um does not occur if i6A is not
present in the tRNA (30).
Many tRNAs that translate codons with U in their 59 posi-
tion contain i6A at position 37 (4, 5, 13). The absence of this
modification dramatically reduces the efficiency of the altered
tRNA in decoding nonsense codons in bacteria and yeast, and
its presence apparently restricts wobble and prevents misread-
ing (4, 5, 13). Chinese hamster ovary (CHO) cells transiently
transfected with an i6A2 tRNA[Ser]Sec gene showed marginal
inhibition of endogenous selenoprotein synthesis but about
80% inhibition of selenoprotein type 1 deiodinase synthesized
by cotransfection of an expression construct encoding the gene
for this selenoprotein (47). In this same study, CHO cells
treated with lovastatin, an inhibitor of the rate-limiting step in
the biosynthesis of i6A, resulted in the inhibition of both gen-
eral selenoprotein synthesis and type 1 deiodinase. Since all
other i6A-containing tRNAs would also be expected to lack
this modified base, the use of lovastatin did not distinguish
between the possible effects of i6A2 tRNA[Ser]Sec and other
i6A-lacking tRNAs on selenoprotein synthesis.
In the present study, transgenic mice containing from 2 to 20
wild-type tRNA[Ser]Sec transgenes or from 2 to 40 i6A2
tRNA[Ser]Sec transgenes were generated, and the effects of
overexpression of wild-type tRNA[Ser]Sec and expression of the
mutant tRNA[Ser]Sec on tRNA maturation and selenoprotein
synthesis in several tissues was examined. The results of these
studies are described herein.
MATERIALS AND METHODS
Materials. [75Se]selenious acid (specific activity, 1,000 Ci/mmol) was obtained
from the Research Reactor Facility, University of Missouri (Columbia, Mo.),
[a-32P]dCTP and [g-32P]ATP (specific activities, ;6,000 Ci/mmol each) were
obtained from New England Nuclear, [3H]serine (specific activity, 36 Ci/mmol)
and Hybond-N1 nylon membranes were obtained from Amersham, polynucle-
otide kinase and reverse transcriptase were obtained from Boehringer Mann-
heim, the RNeasy kit was obtained from Qiagen, human b-actin cDNA probe
was obtained from Clontech, and NACS PREPAC ion exchange columns, re-
striction endonucleases, and agarose were obtained from Gibco-BRL. All other
reagents were commercial products of the highest grade available. Inbred FVB/N
mice were obtained from Charles River (Frederick, Md.), and B6SJL hybrid mice
were from Jackson Laboratories, Bar Harbor, Maine. The care of animals was in
accordance with the National Institutes of Health institutional guidelines under
the expert direction of G. Lidl (National Cancer Institute, NIH, Bethesda, Md.).
Transgenic mice and excision of tissues and organs. A 2.17-kb StuI-PvuII
fragment containing 1.93 kb of mouse DNA encoding the wild-type tRNA[Ser]Sec
gene (41) and 0.24 kb of pBluescript II vector DNA was used for developing a
colony of B6SJL hybrid transgenic mice carrying the wild-type transgene at the
National Institute of Child Health and Human Development Transgenic Mouse
Development Facility, University of Alabama. In vitro mutagenesis was used to
alter a T to a C at position 9 of the tRNA[Ser]Sec gene or to alter an A to a G at
the nucleotide immediately 39 to the anticodon at position 37 using the same
2.17-kb StuI-PvuII fragment, and these fragments were used to develop addi-
tional colonies of transgenic animals encoding either the “wild type” (i.e., the
T-to-C transition position at position 9) or the i6A-deficient (position 37) trans-
gene in FVB/N mice. Transgenic mice were derived by pronuclear microinjection
of fertilized eggs as previously described (8). Tissues and organs were taken from
sacrificed mice, immediately placed into liquid nitrogen, and stored at 280°C
until ready for use.
Southern blot analysis and gene copy number. Genomic DNA was isolated
from mouse tails (38) as modified by Promega, digested with XhoI, electropho-
resed on 1% agarose gels, and transferred to a nylon membrane, and the mem-
brane was cross-linked in an UV-Stratalinker (from Stratagene) by standard
techniques. The membrane was hybridized with a 32P-labeled 240-bp fragment
encoding the Bluescript II vector DNA that was integrated into the mouse
genome as part of the transgene (see Fig. 1), and after obtaining an autoradio-
gram, the filter was stripped and then hybridized with a 32P-labeled 193-bp
fragment of human DNA encoding the tRNA[Ser]Sec gene (43). Probes were
labeled with [a-32P]dCTP using a random primer labeling kit (Stratagene) and
used in hybridization assays, the resulting membranes were washed, and auto-
radiograms were prepared as described previously (40). This procedure was used
to establish transgene number in mice encoding a low copy number (2 to 4
transgenes).
Gene copy number in transgenic mice encoding the higher numbers of trans-
genes (8 to 40) was calculated using the technique employed by the National
Institute of Child Health and Human Development Transgenic Mouse Devel-
opment facility at the University of Alabama. Fifteen mictograms of mouse tail
DNA was digested with XhoI, electrophoresed, transblotted, and hybridized with
probe. The relative intensity of the resulting signal was compared to those
obtained from aliquots of the 2.17-kb fragment encoding the tRNA[Ser]Sec gene
and vector DNA (see Fig. 1) run on the same gel as the genomic DNA, whereby
one gene copy of the fragment encoding the tRNA[Ser]Sec gene represented 5.423
pg.
Isolation and aminoacylation of tRNA, RPC-5 chromatography, and Northern
blot analysis. Total tRNA was isolated from tissues, prepared for aminoacyla-
tion, and aminoacylated with [3H]serine under limiting tRNA conditions (21),
and the resulting labeled seryl-tRNA was chromatographed twice on an RPC-5
column (29), first in buffer without Mg21 and then in buffer with Mg21 (9, 15, 22,
40). Seryl-tRNASer is more hydrophobic than seryl-tRNA[Ser]Sec in the absence
of Mg21 and therefore elutes later on the RPC-5 column, and it is less hydro-
phobic in the presence of Mg21 and therefore elutes earlier. Thus, the tRNASer
and tRNA[Ser]Sec populations can be chromatographically resolved from each
other and quantitated following labeling with [3H]serine as described previously
(9, 15, 22, 40).
Northern blot analysis of GPX1, GPX4, D1, TR1, SPS2, and SelP mRNAs was
carried out by isolating total RNA from liver and kidney using an RNeasy minikit
(according to the vendor’s instructions). The RNA was electrophoresed on a 1%
formaldehyde–agarose gel and transblotted to a nylon membrane. Filters were
probed with a 32P-labeled bovine GPX1 cDNA EcoRI-HindIII fragment (28),
and several IMAGE Consortium (LLNL) cDNA clones were generated as a
MluI-SalI fragment encoding the SPS2 gene (IMAGE Consortium Clone ID
791719 [accession number {AN} AA414662]) and as NotI-EcoRI fragments
encoding the D1, TR1, SelP, and GPX4 genes (IMAGE Consortium Clone ID
677180 [AN AA212899], 676579 [AN AA209061], 777018 [AN AA276440], and
1364475 [AN AI006169]), respectively. Membranes were stripped and reprobed
with 32P-labeled human b-actin cDNA probe.
Primer extension. The identity of the nucleotide at position 9 in the tRNA[Ser]Sec
transgene was used to distinguish the contributions of the product from the
transgenes and that of the wild-type genes to the total tRNA[Ser]Sec population
in transgenic mice by primer extension. An oligonucleotide, 59-GCCTGCACC
CCAGACCACTGA-39, that was complementary to bases 12 through 32 within
VOL. 21, 2001 SELENOCYSTEINE tRNA TRANSGENIC MICE 3841
 at UNIV O
F NEBRASKA-LINCO
LN on M
ay 10, 2007 
m
cb.asm
.org
D
ow
nloaded from
 
the tRNA[Ser]Sec gene was 59-end labeled with [g-32P]ATP and polynucleotide
kinase, the unlabeled nucleotide was removed with a NACS PREPAC column,
and the resulting labeled oligonucleotide was used as a primer in primer exten-
sion studies as described previously (40). The extension buffer included ddATP,
resulting in termination at the first U in the tRNA template. Relative intensities
of bands were determined using a Bio-Rad GS-710 calibrated imaging spectro-
photometer.
Labeling of selenoproteins. Transgenic and wild-type mice were injected in-
traperitoneally with 50 mCi of 75Se/g of body weight and sacrificed at 48 h after
injection, and tissues and organs were excised and immediately placed into liquid
nitrogen and stored at 280°C until ready for use. Tissues were homogenized in
a solution containing 40 mM Tris-HCl (pH 7.4), 1 mM EDTA, and 0.5 mM
4-(-2-aminoethyl)benzenesulfonyl fluoride, sonicated for 2 min, and centrifuged
at 4°C for 20 min. Supernatants were electrophoresed on sodium dodecyl sulfate-
polyacrylamide gels, separated proteins were transferred to nylon membranes,
and transblots were exposed to a PhosphorImager as described previously (20,
40). Gels were stained with Coomassie blue.
Selenoprotein assays. GPX1 (40) and GPX3 (32) activities were assayed as
previously described and measured as the nanomoles of NADPH oxidized/
minute/milligram of protein using H2O2 as substrate. 59-Deiodinase activity was
measured using 125I-reverse T3 or 125I-T4 for type 1 (D1) or type 2 (D2)
deiodinase, respectively, as previously described (3, 18). Thioredoxin reductase
activity was determined in the presence of Escherichia coli thioredoxin using the
insulin reduction method (1) in tissue extracts prepared as described below.
SelP, TR1, TR3, GPX4, and SelT were all measured by Western analysis. In
addition, TR1 and TR3 were measured by 75Se labeling. SelP was measured
using antibody #695 as described previously (24). For thioredoxin reductase
assays, 0.8 g of 75Se-labeled mouse liver from each type of transgenic line were
sonicated in 5 volumes of 25 mM Tris-HCl (pH 7.5)–1 mM EDTA–1 mM
phenylmethylsulfonyl fluoride–5-mg/ml aprotinin–5-mg/ml leupeptin–5-mg/ml
pepstatin A. After centrifugation, the supernatants were separately applied onto
0.5 ml ADP-Sepharose columns. The columns were washed with 0.5 ml of 25 mM
Tris-HCl buffer (pH 7.5)–1 mM EDTA–0.15 M NaCl, and the proteins were
eluted with 1 ml of 25 mM Tris-HCl (pH 7.5)–1 mM EDTA–1.0 M NaCl. The
eluted fractions were tested for thioredoxin reductase activity and also analyzed
by immunoblot assays with rabbit polyclonal antibodies specific for TR1 and TR3
(45) and by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analyses
followed by PhosphorImager assays to determine the 75Se content (20). All
thioredoxin reductase analyses were performed in parallel for the entire set of
samples.
SelT and GPx4 were analyzed with rabbit polyclonal antibodies raised against
the C-terminal peptide of SelT (31) or an internal peptide of GPX4 (antibodies
were kindly provided by Donna Driscoll), respectively. Crude extracts used for
these assays were prepared as for the thioredoxin reductase analyses. X-ray films
were quantified with a densitometer.
Blood and selenium analyses. Blood samples were taken from mice by venal
eye puncture. The serum was obtained by centrifugation and used for determin-
ing cholesterol, triglycerides, liver function (aspartate aminotransferase, alanine
aminotransferase, alkaline phosphatase, total bilirubin, and total protein) and
kidney function (creatinine, urea nitrogen, and uric acid) in the National Insti-
tutes of Health Clinical Center using standard techniques. The amount of sele-
nium in plasma or soft tissues was determined by automated electrothermal
atomic absorption spectrometry using a Varian Spectra AA600 (Varian Instru-
ments, Inc., Walnut Creek, Calif.) equipped with Zeeman-effect background
corrections. Soft tissues were homogenized in 10% HNO3, allowed to digest for
48 h at room temperature, and centrifuged (1,000 3 g), and selenium was
analyzed in the supernatant. Samples of plasma or tissue digests were mixed with
3 volumes of a matrix modifier solution (1.25% Ni[NO3]2.6H2O, 0.09% PdCl2,
0.1% Triton X-100). Absorption was measured at 196.3 nm with a 2.0-nm slit
signal; peak area is calibrated automatically using aqueous solutions of Na2SeO3
as standards. The limit of detection of this method is ca. 5 pg of Se, which yields
a practical detection limit of approximately 20 ng of selenium/ml of sample.
Quality control was effected using multiple aliquots of exhaustively analyzed
human plasma as external control samples with a coefficient of variation of .7%
(for duplicate analyses) used as the criterion for acceptance of all sample results.
That criterion was derived experimentally using the variance components anal-
ysis described previously (37).
RESULTS
Transgenic animals. Transgenic mice were independently
generated using two tRNA[Ser]Sec gene constructs that differ
from each other by a single pyrimidine transition (U3C) at
position 9. C at position 9, which corresponds to wild-type
chicken and Xenopus tRNA[Ser]Sec (33), permitted us to assess
the levels of tRNAs derived from transgenes relative to the
endogenous tRNA[Ser]Sec population. Transgenic mice were
also generated by the introduction of a third tRNA[Ser]Sec gene
containing a purine transition (A3G) immediately 39 to the
anticodon at position 37 (see reference 26 and references
therein for numbering of tRNA[Ser]Sec nucleotide positions).
The change at this position prevents the formation of the
highly modified base, i6A (30), that normally occurs at this site.
The cloverleaf model of tRNA[Ser]Sec, as well as the two de-
scribed altered sites, are shown in Fig. 1A.
Transgenic mice were generated by introducing 2.17 kb of
DNA containing 1.93 kb of mouse DNA and 0.24 kb of vector
DNA (Fig. 1B). The vector sequence is located 425 bp down-
stream of the 39 end of the tRNA[Ser]Sec gene and was used to
monitor integration of the 2.17-kb fragment into the host ge-
nome and for determining the gene copy number. Since trans-
genes often integrate into genomes in a tandem, head-to-tail
manner, Fig. 1B shows the expected result of integration of
tandem 2.17-kb fragments into genomic DNA.
Founder mice were obtained with each of the two “wild-
type” tRNA[Ser]Sec gene constructs and used to establish
mouse lines containing 2 (heterozygous genotype) and 4 (ho-
mozygous genotype) tRNA[Ser]Sec transgene copies of the un-
altered wild-type construct and 10 (heterozygous) to 20 (ho-
mozygous) copies of the construct carrying the U3C change at
position 9. They were designated 1/1/TGWT2 and 1/1/
TGWT2/TGWT2 and 1/1TG“WT”10 and 1/1/TG“WT”10/
TG“WT”10, respectively (see Table 1). Three founders were
obtained with the alteration at position 37 (i6A2), and the
resulting mouse lines generated from these founders contained
2 to 4, 8 to 16, and 20 to 40 transgenes, respectively, and were
designated 1/1/TGi6A22 and 1/1/TGi6A22/TGi6A22, 1/1/
TGi6A28 and 1/1/TGi6A28/TGi6A28, and 1/1/TGi6A220
and 1/1/TGi6A220/TGi6A220 (Table 1).
Analysis of the tRNA[Ser]Sec population. To assess changes
in the tRNA[Ser]Sec population in animals bearing the above-
described transgenes, tRNA was prepared from the liver, kid-
ney, brain, and testes of transgenic wild-type and sibling mice.
Isolated tRNA was aminoacylated with [3H]serine, resulting in
the labeling of tRNASer and the mcm5U and mcm5Um
tRNA[Ser]Sec isoforms. The amounts of the Sec isoacceptors
relative to the seryl-tRNA population were determined by
RPC-5 chromatography, where the unmethylated isoform,
mcm5U, elutes first and the methylated form, mcm5Um, elutes
second from the column (see Materials and Methods) (9, 15,
22, 40). A typical chromatographic separation of the Sec iso-
forms from livers of 1/1, 1/1/TGWT2, and 1/1/TGWT2/
TGWT2 sibling mice is shown in Fig. 2. The tRNA[Ser]Sec
population increased with increasing wild-type gene copy num-
bers in the livers of transgenic animals, and the relative distri-
butions of mcm5U and mcm5Um were altered, albeit slightly.
The relative amounts of the seryl-tRNA[Ser]Sec population and
the distributions of the mcm5U and mcm5Um isoacceptors
from each selected organ were determined in this manner. The
data from liver, kidney, brain, and testes of transgenic mice
harboring wild-type tRNA[Ser]Sec transgenes are summarized
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in Table 2, and those from transgenic mice harboring the i6A2
transgenes are summarized in Table 3.
Overexpression of the wild-type tRNA[Ser]Sec population.
The increase in the tRNA[Ser]Sec population was clearly not
directly proportional to gene copy number in transgenic ani-
mals carrying wild-type transgenes, nor was it the same in all
tissues. For example, the increase was about 3.5-fold in the
liver but more than 6-fold in brains of mice carrying 20 extra
FIG. 1. Secondary structure of tRNA[Ser]Sec and map of the construct used in making transgenic mice. (A) The cloverleaf model of tRNA[Ser]Sec
is shown along with the sites of base changes at positions 9 and 37 used in this study and the sites of modified nucleosides (see the text). The
numbering system for positions within tRNA[Ser]Sec is described in the text. (B) The map shows tandem 2.17-kb transgenic fragments containing
1.93 kb of mouse DNA (large open rectangles) encoding the tRNA[Ser]Sec gene (small dotted rectangles) and 0.24 kb of vector DNA (small solid
rectangles). The AccI (located 48 bp upstream of the coding sequence of the tRNA[Ser]Sec gene) and XhoI (located in the multiple cloning site of
the BlueScript II cloning vector) restriction sites are shown. The 39 end of the tRNA[Ser]Sec gene is located 425 bp upstream of the 59 end of the
vector sequence. The small arrow inside the gene near the 59 end shows the position of the T-to-C mutation at position 9 that distinguishes the
two wild-type tRNA[Ser]Sec transgenes (see the text), and the other arrow inside the gene shows the position of the A-to-G mutation at position
37 that constitutes the i6A2 mutant transgene.
TABLE 1. Transgenic mice
Mouse
straina Transgene
b No. of transgene
copiesc (genotype) Genotype designation
B6SJL Wild type 2 (heterozygous) 1/1/TGWT2
4 (homozygous) 1/1/TGWT2/TGWT2
FVB/N “Wild type” (T3C) at position 9d 10 (heterozygous) 1/1/TG“WT”10
20 (homozygous) 1/1/TG“WT”10/TG“WT”10
FVB/N i6A2 mutant (A3G) at position 37d 2 (heterozygous) 1/1/TGi6A22
4 (homozygous) 1/1/TGi6A22/TGi6A22
8 (heterozygous) 1/1/TGi6A28
16 (homozygous) 1/1/TGi6A28/TGi6A28
20 (heterozygous) 1/1/TGi6A220
40 (homozygous) 1/1/TGi6A220/TGi6A220
a A single founder was generated with the B6SJL strain using the wild-type tRNA[Ser]Sec gene construct and with the FVB/N strain using the wild-type construct
harboring an A3C mutation at position 9. Three founders were generated with the FVB/N strain using the i6A2 mutant tRNA[Ser]Sec construct.
b Constructs encoding the tRNA[Ser]Sec gene (see Materials and Methods) used for making transgenic mice.
c The number of transgene copies was established as described in Materials and Methods.
d The T3C mutation was generated at position 9 and the A3G mutation at position 37 as described in Materials and Methods.
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tRNA[Ser]Sec copies (Table 2). In addition, the relative distri-
butions of the two tRNA[Ser]Sec isoforms in tissues of mice
carrying wild-type transgenes were altered as gene copy num-
bers increased. As shown in Table 2, the amount of mcm5U
relative to that of mcm5Um increased slightly in the TGWT2
animals, but this effect was more dramatic in the TG“WT”10
animals. These observations support the hypothesis that the
methylase responsible for converting mcm5U to mcm5Um is
likely to be limiting (see also references 23 and 40).
The introduced nucleotide change at position 9 in the
FIG. 2. Relative amounts of mcm5U and mcm5Um isoacceptors in livers of wild-type and heterozygous and homozygous transgenic mice
bearing wild-type transgenes. Total tRNA was isolated from livers of littermates bearing 1/1, 1/1/TGWT2, and 1/1/TGWT2/TGWT2 genotypes
and aminoacylated with [3H]serine, and the resulting 3H-labeled tRNA was fractionated as described in Materials and Methods. The amounts of
seryl-tRNA[Ser]Sec (mcm5U is the first eluting peak and mcm5Um is the second) found in livers of heterozygous and homozygous transgenic mice
were standardized to that found in wild-type livers with the total [3H]seryl-tRNASer serving as an internal control. Sources of seryl-tRNA[Ser]Sec
are shown in each graph.
TABLE 2. Levels and distributions of wild-type tRNA[Ser]Sec isoforms in organs of transgenic micea
Tissue Genotype of offspring
Result for tRNA[Ser]Sec
%
(Total)b
Relative
amtc
Distributiond
mcm5U (%) mcm5Um (%) mcm5U/mcm5Ume
Liver 1/1 2.4 1.00 49 51 0.97
1/1/TGWT2 3.9 1.79 52 48 1.08
1/1/TGWT2/TGWT2 5.4 2.20 55 45 1.23
Liver 1/1 2.5 1.00 46 54 0.83
1/1/TG“WT”10 6.4 2.53 72 28 2.60
1/1/TG“WT”10/TG“WT”10 9.4 3.69 81 19 4.29
Kidney 1/1 3.5 1.00 32 68 0.48
1/1/TGWT2 6.8 1.95 39 61 0.63
1/1/TGWT2/TGWT2 7.4 2.13 39 61 0.64
Kidney 1/1 3.8 1.00 38 62 0.61
1/1/TG“WT”10 12.8 3.67 63 37 1.67
1/1/TG“WT”10/TG“WT”10 19.8 5.68 71 29 2.45
Brain 1/1 3.2 1.00 26 74 0.35
1/1/TGWT2 5.9 1.79 38 62 0.62
1/1/TGWT2/TGWT2 7.0 2.10 40 60 0.66
Brain 1/1 3.5 1.00 27 73 0.37
1/1/TG“WT”10 13.5 3.82 59 41 1.43
1/1/TG“WT”10/TG“WT”10 21.6 6.09 66 34 1.91
Testes 1/1 8.8 1.00 67 33 2.07
1/1/TGWT2 7.9 0.90 68 32 2.17
1/1/TGWT2/TGWT2 11.5 1.31 69 31 2.24
Testes 1/1 8.4 1.00 68 32 2.14
1/1/TG“WT”10/TG“WT”10 19.8 2.31 76 24 3.08
a tRNA was isolated from liver, kidney, brain and testes tissues (column 1) of offspring (column 2) from matings of heterozygous parents (1/1/TGWT2 3
1/1/TGWT2 or 1/1/TG“WT”10 3 1/1/TG“WT”10) and tRNA fractionated, tRNA[Ser]Sec was isolated, and the amounts of total tRNA[Ser]Sec (columns 3 and 4) and
the distributions of mcm5U and mcm5Um (columns 5 to 7) were determined as described in Materials and Methods.
b Percentage of tRNA[Ser]Sec population within the total seryl-tRNA population.
c Amount of the tRNA[Ser]Sec population relative to that in the wild type, which was assigned a value of 1.00.
d Percentages of mcm5U and mcm5Um resolved by RPC-5 chromatography from the seryl-tRNA population (see Materials and Methods).
e Amount of mcm5U divided by the amount of mcm5Um.
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tRNA[Ser]Sec transgene permitted us to distinguish the amount
of gene product contributed to the tRNA[Ser]Sec population by
the transgenes relative to that from the host genes by primer
extension. Total tRNA from livers, kidneys, and testes of trans-
genic mice and their wild-type siblings was used as a template
to extend the sequence of an oligonucleotide complementary
to positions 12 through 32. Since ddATP replaced dATP in the
extension buffer, primers were extended until a U was encoun-
tered in the template tRNA. The primer was therefore ex-
tended only three nucleotides when wild-type tRNA[Ser]Sec was
used as a template and six nucleotides when transgene-derived
tRNA[Ser]Sec was used as a template. As expected, the oligo-
nucleotide extended only three nucleotides in tRNA samples
isolated from livers, kidneys (Fig. 3A, lanes 2 and 5, respec-
tively), and testes (data not shown) of the wild-type siblings. In
contrast, total tRNA from these same tissues obtained from
heterozygous and homozygous transgenic animals contained
the expected extension products for tRNA transcribed from
the transgenes (Fig. 3A, lanes 3, 4, 6, and 7, respectively).
Transfer RNA was also recovered from column fractions
representing either the mcm5U or the mcm5Um isoacceptor
and assayed by primer extension as described above for total
tRNA. Extension products indicative of transgene origin were
also present when tRNA from the earlier-eluting isoacceptor
(mcm5U) (Fig. 3B) and the later-eluting isoacceptor (mcm5Um)
(Fig. 3C) were used as substrates, indicating that both isoforms
of the transgene-derived tRNA were capable of full matura-
tion.
The column profile analysis indicated that the increase in
tRNA[Ser]Sec obtained by increasing the transgene copy num-
ber from 10 to 20 did not result in a comparable doubling of
tRNA[Ser]Sec levels (Table 2); and this observation was verified
by the primer extension data presented in Fig. 3A. To deter-
mine the relative contributions of transgenes and host genes to
the observed increase in the tRNA[Ser]Sec population, we took
advantage of our experimental design, which permitted the
independent quantitation of endogenous and transgene-de-
rived tRNA[Ser] by primer extension. Quantitation of the lower
bands (endogenous) by densitometry indicated that the levels
of the host tRNA[Ser]Sec declined by 30 to 75% with an increas-
ing tRNA[Ser]Sec gene copy number for all tissues examined,
and clear dose responses were observed for the kidney and
liver (Fig. 3A).
Expression of the i6A2 transgenes. The tRNA[Ser]Sec popu-
lation was examined in selected organs of transgenic mice
containing tRNA[Ser]Sec genes engineered to be incapable of
TABLE 3. Levels and distributions of wild-type and i6A2 mutant tRNA[Ser]Sec isoforms in organs of transgenic micea
Tissue Genotype of offspring
Results for tRNA[Ser]Sec
% (Total) Distribution
WT i6A2 mcm5U (%) mcm5Um (%) mcm5U/mcm5Um
Liver 1/1b 2.5 0 46 54 0.85
1/1/TGi6A22 1.8 3.6 56 44 1.27
1/1/TGi6A22/TGi6A22 2.2 4.7 61 39 1.56
1/1/TGi6A28 2.5 12 60 40 1.50
1/1/TGi6A28/TGi6A28 2.4 15 65 35 1.86
1/1/TGi6A220 2.3 20 67 33 2.03
1/1/TGi6A220/TGi6A220 2.6 31 72 28 2.57
Kidney 1/1b 3.8 0 34 66 0.52
1/1/TGi6A22 4.0 8.8 42 58 0.72
1/1/TGi6A22/TGi6A22 4.1 10.1 43 57 0.75
1/1/TGi6A28 3.9 15.1 54 46 1.17
1/1/TGi6A28/TGi6A28 3.5 13.4 64 36 1.78
1/1/TGi6A220 3.3 18.6 63 37 1.70
1/1/TGi6A220/TGi6A220 3.9 30.1 66 34 1.94
Brain 1/1b 5.0 0 35 65 0.54
1/1/TGi6A22 4.7 7.0 47 53 0.89
1/1/TGi6A22/TGi6A22 4.9 8.5 49 51 0.96
1/1/TGi6A28 5.1 14.9 48 52 0.92
1/1/TGi6A28/TGi6A28 4.8 26.0 54 46 1.17
1/1/TGi6A220 4.7 34.5 58 42 1.38
1/1/TGi6A220/TGi6A220 4.8 41.2 60 40 1.50
Testes 1/1b 8.4 0 68 32 2.13
1/1/TGi6A22 7.8 4.9 72 28 2.57
1/1/TGi6A22/TGi6A22 7.6 6.0 73 27 2.70
1/1/TGi6A28 7.3 10.9 74 26 2.85
1/1/TGi6A28/TGi6A28 6.5 12.1 79 21 3.76
1/1/TGi6A220 6.0 12.9 79 21 3.76
1/1/TGi6A220/TGi6A220 5.7 22.2 80 20 4.00
a See the footnotes to Table 2 and Materials and Methods for details. WT, wild type.
b As the levels of the tRNA[Ser]Sec population and the distributions of mcm5U and mcm5Um were similar for siblings of wild-type control mice from both mouse lines
(see Table 2), only tissues from wild-type mice obtained from heterozygous matings between parents containing the lowest mutant tRNA gene copy number were used
to establish control values.
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forming the i6A modification. The i6A2 tRNA[Ser]Sec elutes
earlier from the RPC-5 column than the endogenous i6A-
containing tRNA[Ser]Sec population (10, 30, 42, 47) while re-
taining its ability to be aminoacylated (42, 47). These observa-
tions facilitated the analysis of each of the tRNA[Ser]Sec species
for the liver, kidney, brain, and testes. The total amount of the
host tRNA[Ser]Sec population remained virtually unchanged in
livers, kidneys and brains of these mice, even though the i6A2
form increased to levels as high as about 30 to 40% of the total
tRNASer population in mice carrying the highest transgene
copy number (Table 3). In testes, the level of endogenous
tRNA declined slightly as the level of i6A2 tRNA increased.
Examination of the distributions of mcm5U and mcm5Um in
animals expressing i6A2 tRNA[Ser]Sec indicated that there was
an increase in mcm5U with a proportional decline in mcm5Um
in the livers, kidneys, and brains of these animals. The data also
suggest that the levels of wild-type tRNA[Ser]Sec and i6A2
tRNA[Ser]Sec are regulated independently of each other and
that the level of the tRNA[Ser]Sec population is determined in
these tissues, at least in part, by a feedback mechanism gov-
erned by the isoforms containing i6A at position 37 (see Dis-
cussion).
Protein synthesis. Selenoprotein biosynthesis was assessed
in the transgenic mice described above by injection with 75Se.
Proteins from livers, kidneys, testes, brains, muscles, and hearts
of these and control animals were isolated following labeling
with 75Se and examined by gel electrophoresis. Coomassie
blue-stained gels of total proteins from these tissues showed
only minor differences in protein patterns in transgenic mice
containing 10 to 20 wild-type transgenes compared to results
for their wild-type, nontransgenic siblings (data not shown).
PhosphorImaging, used specifically to detect 75Se-labeled sel-
enoproteins, also failed to detect significant differences be-
tween transgenic and corresponding control tissues. Therefore,
the higher levels of tRNA[Ser]Sec resulting from the expression
of 2 to 4 and 10 to 20 wild-type transgene copies had little or
no effect on either general protein synthesis or selenoprotein
levels (data not shown).
In contrast to the data presented above, the presence of
i6A2 tRNA[Ser]Sec caused considerable changes in selenopro-
tein synthesis. Seven tissues, including the cerebellum, were
excised from 75Se-labeled mice, and the resulting protein ex-
tracts were electrophoresed. Coomassie blue staining of total
protein within gels showed some variations in tissue extracts
from either wild-type or heterozygous and homozygous i6A2
tRNA[Ser]Sec transgenic mice (Fig. 4A, C, and E). No consis-
tent differences were observed, however, when duplicate sam-
ples of sibling mice were analyzed (data not shown). In con-
trast, 75Se-labeled proteins were significantly altered in the
tissues of these mice, with selenoprotein patterns being differ-
ent in each of the seven tissues examined (Fig. 4B, D, and F).
For example, there was an apparent decrease in GPX1 in the
livers of transgenic mice carrying two or more i6A2 tRNA[Ser]Sec
transgenes (Fig. 4B, D and F) and in kidneys of mice carrying
eight or more i6A2 tRNA[Ser]Sec transgenes (Fig. 4D and F).
GPX1 levels appeared to be less affected in kidney than liver in
mice with genotype 1/1/TGi6A28 or 1/1/TGi6A28/TGi6A28
(Fig. 4D).
In addition to assessing selenoprotein levels by quantifying
75Se-labeled proteins, several selenoproteins were analyzed di-
rectly by enzymatic assay or Western analyses. These assays
confirmed that the levels of several selenoproteins were dra-
FIG. 3. Characterization of tRNA[Ser]Sec obtained from tissues of wild-type mice and heterozygous and homozygous transgenic mice bearing
transgenes with a pyrimidine transition at position 9 by primer extension. Total tRNA (A), fractionated mcm5U (B), or fractionated mcm5Um (C)
was used as a template for primer extension. Column fractions were selected to minimize the overlap of the peaks representing each isoacceptor.
In each panel, the order of samples is as follows: lane 1, no template; lane 2, 1/1 liver; lane 3, 1/1/TG“WT”10 liver; lane 4, 1/1/TG“WT”10/
TG“WT”10 liver; lane 5, 1/1 kidney; lane 6, 1/1/TG“WT”10 kidney; and lane 7, 1/1/TG“WT”10/TG“WT”10 kidney. Preparation, separation, and
recovery of tRNA and tRNA fractions and primer extensions were done as described in Materials and Methods. The positions of the primer and
the 13 (host tRNA[Ser]Sec) and 16 (transgene tRNA[Ser]Sec) extension products are indicated.
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FIG. 4. Protein and selenoprotein analysis in tissues of wild-type and sibling heterogeneous and homogenous i6A-deficient transgenic mice.
Littermates were labeled with 75Se, and proteins were extracted from the different tissues, electrophoresed, and transblotted onto a membrane;
the membrane was stained with Coomassie blue. Total protein of 1/1, 1/1/TGi6A22, and 1/1/TGi6A22/TGi6A22 (A), 1/1, 1/1/TGi6A28, and
1/1/TGi6A28/TGi6A28 (C), and 1/1, 1/1/TGi6A220, and 1/1/TGi6A220/TGi6A220 (E) mice and 75Se-labeled proteins of 1/1, 1/1/
TGi6A22, and 1/1/TGi6A22/TGi6A22 (B), 1/1, 1/1/TGi6A28, and 1/1/TGi6A28/TGi6A28 (D), and 1/1, 1/1/TGi6A220, and 1/1/
TGi6A220/TGi6A220 (F), mice were detected with a PhosphorImager as described in Materials and Methods. Protein marker sizes are shown on
the left of each panel as indicated by the arrows.
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FIG. 4—Continued.
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matically reduced in all tissues examined, while others were
selectively reduced in one tissue but not in another. At least
one selenoprotein, TR3, appeared to be more highly ex-
pressed, while GPX1 activity was decreased in every tissue
examined (Table 4). A dose-dependent effect was observed for
GPX1 activities, since tissues from mice expressing less of the
i6A2 tRNA[Ser]Sec exhibited more GPX1 activity than those
expressing more of the i6A2 tRNA[Ser]Sec (Table 4). A similar
dose-dependent effect was observed for the inhibition of
GPX3, which is synthesized in the kidney and secreted into
plasma. The effects of the expression of i6A2 tRNA[Ser]Sec on
GPX4, deiodinase 1 (D1 synthesized in the liver), deiodinase 2
(D2, synthesized in the pituitary gland), and SelP (synthesized
primarily in the liver and secreted to plasma), TR1, and SelT
(31) are also presented in Table 4. The tissue specificity of
these effects is particularly apparent in the testes, where as
much as an 80% reduction in GPX1 was observed while the
levels of GPX4, TR3, and SelT were either unaffected or stim-
ulated.
Northern blot analysis. The data presented above cataloging
the reduced amounts of selenoproteins in organs of transgenic
mice could be explained by effects on either transcription or
translation. Therefore, we examined the mRNA levels of sev-
eral selenoproteins by Northern analysis. GPX1 activity was
dramatically reduced in i6A2 tRNA[Ser]Sec-expressing animals,
as judged by both 75Se labeling and direct enzyme assay. GPX1
mRNA levels were measured by Northern blot analysis in liver
and kidney tissue of transgenic mice, where it was apparent
that the amount of GPX1 mRNA was virtually unchanged in
these two tissues, with the possible exception in livers of mice
carrying the highest number of mutant tRNA[Ser]Sec transgenes
(Fig. 5A). We also examined several other selenoprotein
mRNAs, which included SelP, TR1, D1, SPS2, and GPX4 from
livers of mice expressing i6A2 tRNA transgenes (Fig. 5B). In
general, any differences observed in selenoprotein mRNA lev-
els in organs from i6A2 mice were insufficient to account for
the reduction observed in the corresponding selenoproteins.
The data therefore indicate that the defect in selenoprotein
biosynthesis caused by expression of the i6A-deficient
tRNA[Ser]Sec occurs at the translation step. Warner et al. (47)
have also shown that CHO cells transfected with an i6A2
tRNA[Ser]Sec gene exhibited reduced type 1 deiodinase levels
without affecting steady-state levels of the corresponding
mRNA.
Selenium levels and blood chemistries. Selenium levels in
livers, kidneys, brains, testes, and serum of selected transgenic
mice and their wild-type siblings were analyzed (Table 5).
Dramatic differences in selenium levels between the i6A2 mice
and their sibling controls were observed in plasma (30 to 60%),
liver, kidney, and heart, while the difference was less apparent
in the testes and brain.
No overt signs of ill health were observed in animals over-
expressing either wild-type or i6A2 transgenes as evidenced by
their phenotypic appearance or behavior. Their blood chemis-
tries (see Materials and Methods) fell within the normal ranges
of their wild-type siblings regarding cholesterol, serum triglyc-
erides, and liver and kidney function tests (data not shown).
DISCUSSION
There is a growing appreciation of the diverse biological
roles for selenoproteins and the central role for tRNA[Ser]Sec in
their synthesis. To study the regulation of selenoprotein bio-
synthesis, we generated transgenic mice that expressed ele-
TABLE 4. Levels of selenoproteins in i6A2 mutant tRNA[Ser]Sec transgenic mice and their siblingsa
Selenoprotein Tissue
Level of selenoproteins (% of wild type)b
TGi6A22 TGi
6A22/
TGi6A22 TGi
6A28 TGi
6A28/
TGi6A28 TGi
6A220 TGi
6A220/
TGi6A220
GPX1c Liver 46 22 10 10 5 3
Kidney 30 36 28 24 8 4
Brain 39 56 47 43 ND ND
Testes 99 100 45 40 41 19
GPX3c Plasma (kidney) 57 61 24 16 22 20
GPX4d Liver NDf ND 8 ,5 28 ,5
Testes ND ND 100 100 99 86
D1c Liver 39 15 25 21 15 17
D2c Pituitary ND ND 36 41 60 13
SelPd Plasma (liver) ND ND ND ND 66 45
TR1d Liver 80 60 100 50 60 30
TR3d Liver 102 126 87 111 176 162
TR1/TR3c Liver 65 42 63 67 33 63
TR1/TR3e Liver ND ND 66 89 52 64
SelTd Liver ND ND 57 40 56 43
Kidney ND ND 38 21 42 31
Brain ND ND 63 56 53 42
Testes ND ND 111 107 105 113
a Selenoproteins were analyzed by enzyme activity or Western analysis (see footnotes b and c) as described in Materials and Methods.
b Enzyme activities, immunoblot levels, or 75Se PhosphorImager signals observed in wild-type siblings were considered to represent 100% of selenoprotein expression,
and the values observed in transgenic mice harboring mutant transgenes are reported as the percentage of that found in the corresponding wild-type tissues.
c Activity determined by direct assay.
d Western analysis.
e PhosphorImager analysis.
f ND, not determined.
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vated levels of either wild-type or i6A-deficient tRNA[Ser]Sec
and examined the consequences of these manipulations on
selenoprotein and tRNA[Ser]Sec levels. The generation of the
animals described in this study provides the first example of the
production of transgenic mice in which multiple copies of a
tRNA gene are stably introduced and expressed.
It is evident from our analyses of the tRNA[Ser]Sec popula-
tion in several tissues from these transgenic mice that they can
tolerate relatively high levels of tRNA[Ser]Sec, since some tis-
sues exhibited increases of more than 6-fold in wild-type
tRNA[Ser]Sec or more than 12-fold in i6A2 tRNA[Ser]Sec with-
out apparent ill effects on their health. The use of primer
extension permitted the independent examination of endoge-
nous tRNA[Ser]Sec and that derived from the wild-type trans-
genes, and the data indicated that both contribute to the re-
sulting tRNA population. Using this approach, we observed a
reduction in endogenous tRNA[Ser]Sec with increasing amounts
of tRNA[Ser]Sec derived from wild-type transgenes (Fig. 3).
Levels of i6A-deficient tRNA[Ser]Sec could be directly evaluated
by RPC-5 chromatography, and quantities were correlated
with gene copy number. Levels of i6A-deficient tRNA[Ser]Sec as
high as 40% of the total tRNASer population did not affect the
level of tRNA[Ser]Sec expressed from the corresponding endog-
enous genes. The distributions of mcm5U and mcm5Um, how-
ever, were dramatically affected with increasing amounts of
i6A2 tRNA[Ser]Sec. Their distributions mimicked those seen in
liver and kidney tissue of selenium-deficient rats and mice and
in mammalian cells grown in selenium-deficient medium,
where mcm5Um was significantly reduced (9, 15, 22). Collec-
tively, these observations support the existence of a feedback
mechanism of control that limits the amounts of tRNA[Ser]Sec
found in particular tissues. The effector(s) involved in this
feedback control likely requires the i6A modification at posi-
FIG. 5. Northern analysis of several selenoprotein mRNAs. (A) mRNA levels of GPX1 in liver and kidney of heterozygous and homozygous
transgenic mice carrying the highest number of mutant transgenes and their wild-type siblings are shown. (B) mRNA levels of Se1P, TR1, D1,
SPS2, and GPX4 in liver tissue of homozygous transgenic mice carrying the highest number of mutant transgenes and their wild-type siblings are
shown. mRNA was extracted from livers and kidneys of mice harboring 20 or 40 i6A2 mutant tRNA[Ser]Sec transgenes and their wild-type siblings,
electrophoresed, and transblotted onto membranes. The membranes were hybridized with 32P-labeled probes complementary to each mRNA
shown in both panels, their levels were quantitated by phosphoimagery, and the filters were stripped and rehybridized with b-actin as described
in Materials and Methods.
TABLE 5. Selenium levels in tissues of i6A2 mutant transgenic and
wild-type micea
Tissue Genotype Selenium level
a
(ppb) % Decrease
b
Plasma 1/1 349.2
1/1/TGi6 A22 236.0 32.4
1/1/TGi6A22/TGi6A22 211.3 39.5
1/1 360.7
1/1/TGi6A28 168.2 53.4
1/1/TGi6A28/TGi6A28 141.6 60.7
1/1 310.7
1/1/TGi6A220 163.4 47.4
1/1/TGi6A220/TGi6A220 159.2 48.8
Liver 1/1 777.5
1/1/TGi6A220/TGi6A220 254.4 67.3
Kidney 1/1 649.5
1/1/TGi6A220/TGi6A220 390.2 39.9
Heart 1/1 188.9
1/1/TGi6A220/TGi6A220 109.9 42.8
Brain 1/1 86.6
1/1/TGi6A220/TGi6A220 69.3 19.6
Testes 1/1 512.0
1/1/TGi6A220/TGi6A220 344.2 32.8
a Selenium levels were determined in i6A2 tRNA[Ser]Sec mice and their wild-
type siblings as described in Materials and Methods. Weights of wild-type and
homozygous animals used for selenium organ analysis were 22.4 and 22.8 g,
respectively.
b Percent decrease in selenium level in i6A2 tRNA[Ser]Sec tissues from wild-
type level.
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tion 37. The data also show that the presence of the i6A2
tRNA[Ser]Sec results in an inhibition of the maturation process.
For mice overexpressing wild-type tRNA[Ser]Sec, the increase
was largely restricted to the mcm5U isoform in the tissues
examined. There was no apparent effect on selenoprotein syn-
thesis. These data are consistent with the methylation of
tRNA[Ser]Sec on the ribosyl moiety at position 34 being a lim-
iting step in tRNA maturation (40). As noted previously in
both cell culture (10, 22) and animal models (9, 15), the dis-
tribution of the two major isoforms of mammalian tRNA[Ser]Sec
responds to increased selenium availability with a characteris-
tic increase in mcm5Um and translational induction of GPX1.
This, and the restrictions observed in the conversion to the
mcm5Um seen in vivo, suggest that the balance between
tRNA[Ser]Sec isoacceptors serves a biologically significant pur-
pose that is yet to be defined.
In contrast to the data obtained with the overexpression of
wild-type tRNA[Ser]Sec, selenoprotein synthesis was dramati-
cally affected in mice expressing i6A2 tRNA[Ser]Sec. This was
demonstrated by 75Se labeling of selenoproteins and by direct
enzyme assay and/or Western blot analyses. The expression of
several selenoproteins was reduced substantially in all tis-
sues examined (e.g., GPX1), with a dose-dependent effect
being evident. All selenoproteins examined in this study ap-
peared to be reduced in the livers of i6A2 mice, with the excep-
tion of TR3, which was either unaffected or stimulated. The ex-
pression of other selenoproteins, such as GPX4 and SelT, was
also inhibited in the liver but unaffected in the testes by
increasing amounts of i6A2 tRNA[Ser]Sec. The lack of an effect
in the testes may be due to the fact that the tRNA[Ser]Sec
population in the testes (.7% of the total serine tRNA pop-
ulation) is substantially higher than that in the liver (;2.5% of
the total serine tRNA population). Therefore, the i6A-defi-
cient tRNA[Ser]Sec population represented a much lower pro-
portion of the tRNA[Ser]Sec population in the testes than in the
liver (Table 3). Translation of GPX1 appeared to be particu-
larly sensitive to the presence of i6A2 tRNA[Ser]Sec, consistent
with the possibility that its synthesis may be more dependent
on the mcm5Um isoform than is that of other selenoproteins
(9).
A hierarchy exists with regard to the effects of selenium
deficiency on the maintenance of individual selenoproteins as
well as selenium retention by different organs (2, 24, 34, 36,
39). For example, GPX1 activity was reduced to 1% in liver
tissue and about 4 to 9% in kidney, heart and lung tissues
during selenium deficiency in rats. GPX4 activity, on the other
hand, was reduced only about 25 to 50% in these tissues but
was unaffected in the testes. A similar hierarchy of selenium
maintenance may be occurring in response to the expression of
i6A2 tRNA[Ser]Sec. As seen in Table 4, the levels of each of the
selenoproteins analyzed in i6A2 mice were reduced to different
degrees, and the extent of the reduction differed depending on
the organ examined.
The greater sensitivity of GPX1 activity to selenium defi-
ciency was attributed in large part to increased mRNA turn-
over (11, 34, 44). In contrast, the reduction in GPX1 observed
with increasing amounts of i6A-deficient tRNA is not likely
due to mRNA turnover, since GPX1 mRNA stability was not
significantly altered in kidneys of i6A2 mice. The stem-loop
structure in the 39 untranslated region of mammalian seleno-
protein mRNAs, designated the SECIS element (35), has also
been shown to play a role in establishing a selenoprotein hi-
erarchy (36). Thus, it would appear that there are several levels
of regulation involved in determining the priority of seleno-
protein synthesis under various biological conditions.
Under conditions of selenium deprivation in the diets of rats
and mice, the levels of this element are reduced in the liver and
kidneys, while the brain and testes retain most of their sele-
nium (2, 25). Transfer RNA[Ser]Sec maturation and selenopro-
tein synthesis are responsive to selenium status, and thus these
two parameters are more affected by change in selenium status
in the liver and kidneys than in the testes and brain (15, 25).
Selenoprotein biosynthesis was most affected in the liver, kid-
neys, and brain in the presence of i6A2 tRNA[Ser]Sec and least
affected in the testes, while selenium losses were highest in the
liver and kidneys and lowest in the testes and brain. The losses
in selenium in the brain were the lowest of the tissues exam-
ined, and this reduction may reflect only an inhibition in sel-
enoprotein biosynthesis. Observations showing a differential
loss in selenium retention and differential rates in selenopro-
tein biosynthesis suggest that the i6A2 tRNA[Ser]Sec transgenic
mice can be used as a model system to better understand the
hierarchy in selenium retention by different tissues.
There is an abundance of literature supporting selenium as
a protective agent against a variety of mutagens, carcinogens,
and viruses in laboratory animals, namely rats and mice (re-
viewed in reference 19). Animals given slightly elevated levels
of selenium in their diets have the greatest protection upon
exposure to these environmental stresses. Studies with humans
also support a role of selenium as a beneficial micronutrient in
the diet (17). It is unclear whether these beneficial effects of
selenium on health are due to selenium-containing, low-mo-
lecular-weight compounds (see references 17 and 27 and ref-
erences therein) or to selenium-containing proteins (reviewed
in reference 19). Since transgenic i6A2 tRNA[Ser]Sec mice have
reduced selenoprotein levels, it will be of considerable interest
to determine if slightly elevated levels of dietary selenium will
afford these transgenic mice the same protection from envi-
ronmental stress as their wild-type siblings have.
Since the i6A2 tRNA[Ser]Sec mice selectively express seleno-
proteins, then by controlling the mutant tRNA[Ser]Sec gene
dosage, these animals may be used to provide a useful model
for resolving the roles of individual selenoproteins as well as
their overall influence on health. It is of interest that adult
animals made selenium deficient through diet appear to be as
healthy as their control counterparts maintained on selenium-
sufficient diets unless they are challenged or stressed environ-
mentally. The i6A2 tRNA[Ser]Sec transgenic mice also appear
to be as healthy as their wild-type littermates. By the selective
use of individual carcinogens, mutagens, and viruses and care-
ful monitoring of the rates of malignant change at target sites,
these transgenic mice may be used as a powerful tool for
determining the role of individual selenoproteins in protecting
against specific environmental stresses.
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